Search Results - "Aslanabadi, Nasser"

Hepatitis B virus infection and the risk of coronary atherosclerosis by Ghotaslou, Reza, Aslanabadi, Nasser, Ghojazadeh, Morteza

“…Many studies have reported on the association between human coronary artery disease (CAD) and certain persistent bacterial and viral infections. Currently, it…”
Get more information

Patient's Radiation Exposure in Coronary Angiography and Angioplasty: The Impact of Different Projections by Farajollahi, Alireza, Rahimi, Atena, Khayati Shal, Ebrahim, Ghaffari, Samad, Ghojazadeh, Morteza, Tajlil, Arezou, Aslanabadi, Naser

“…We aimed to determine angiography projections with lower Dose Area Product (DAP) rate by measuring the mean DAP and fluoroscopy times in coronary angiography…”
Get full text

OPTIMA Tacrolimus-eluting Stent: A Twelve-month Clinical Follow up with Two Different Periods of Dual Antiplatelet Therapy; 2-monthvs. 6-month Approach by Nasser Aslanabadi, Ahmad Separham, Reza Beheshti, Samad Ghaffari, Bahram Sohrabi

“…Introduction: There are limited data comparing long-term efficacy and safety of OPTIMA tacrolimus-eluting stent (TES) with Dual Antiplatelet Therapy (DAT) in…”
Get full text

Epicardial and pericardial fat volume correlate with the severity of coronary artery stenosis by Aslanabadi, Nasser, Salehi, Rezvanyeh, Javadrashid, Alireza, Tarzamni, Mohammadkazem, Khodadad, Behrouz, Enamzadeh, Elgar, Montazerghaem, Hossein

“…Epicardial fat volume (EFV) has been reported to correlate with the severity of coronary artery disease (CAD). Pericardial fat volume (PFV) has recently been…”
Get full text

OPTIMA Tacrolimus-eluting Stent: A Twelve-month Clinical Follow up with Two Different Periods of Dual Antiplatelet Therapy; 2-month vs. 6-month Approach by Aslanabadi, Nasser, Separham, Ahmad, Beheshti, Reza, Ghaffari, Samad, Sohrabi, Bahram

“…There are limited data comparing long-term efficacy and safety of OPTIMA tacrolimus-eluting stent (TES) with Dual Antiplatelet Therapy (DAT) in daily practice…”
Get full text